Concept information
Preferred term
Dichlororibofuranosylbenzimidazole
Type
-
mesh:Descriptor
Definition
- An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Broader concept
Entry terms
- 1H-Benzimidazole, 5,6-dichloro-1-beta-D-ribofuranosyl-
- 53-85-0
- 5,6-Dichloro-1-beta-D-ribofuranosyl-1-H-benzimidazol
- 5,6-Dichloro-1-beta-ribofuranosylbenzimidazole
- Dichlorobenzimidazole Riboside
- DRB
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
1H-Benzimidazole, 5,6-dichloro-1-beta-D-ribofuranosyl-
-
53-85-0
URI
http://data.loterre.fr/ark:/67375/JVR-VVP6JZ36-8
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}